A prospective survey was conducted of the indications for and complications of 153 temporary transvenous cardiac pacing lead insertions in 148 patients. Pacing for bradyarrhythmias or potential bradyarrhythmias (Group I) accounted for 105 insertions, wide complex tachycardia (Group Il) 17, and narrow complex tachycardia (Group Ill) 31 pacing electrode insertions respectively. The infraclavicular subclavian vein approach was used in 73%. The median insertion time was 20 minutes. Group I: 77% were undertaken because of severe symptoms. On 64 occasions (61 %) the patient had complete heart block or ventricular asystole. Group Il: The lead was inserted to treat and often assist in the diagnosis of the wide complex tachycardia. Ventricular 'burst' pacing reverted ventricular tachycardia in 13 (76%). Group Ill: Rapid atrial 'burst' pacing was used to treat supraventricular tachyarrhythmias (paroxysmal supraventricular tachycardia and atrial flutter) resistant to medical therapy. Pacing was successful in reverting 28 (90%). A complication occurred in 27 (18%) of 153 lead insertions, 11 (7%) were serious. No complication resulted in the death of a patient. Temporary transvenous pacing is safe and effective for the treatment of bradyarrhythmias and certain tachyarrhythmias.
It is over 30 years since Zoll! externally paced the heart and 25 years since Furman and Robinson 2 described the use of a transvenous right ventricular endocardial pacing electrode in the management of complete heart block. Temporary transvenous pacing has become a widely accepted method for the treatment of bradyarrhythmias. More recently it has been shown that pacing can be used for the treatment and diagnosis of ventricular tachycardia 3 ,4 and certain supraventricular tachyarrhythmias. [4] [5] [6] [7] [8] [9] There are relatively few studies of the complications of temporary transvenous pacing lO -!3 and these are retrospective. The incidence of serious complications is difficult to *M.R.C.P. (Ire1.), F.R.A.C.P., Specialist in Intensive Care. "F.R.A.C.P., B.Med. Se. ascertain although pacemaker malfunction (i.e. failure to pace or sense or both) appears to be very common, occurring in about 40070 of cases.!!,!3 Previous studies appear to have dealt exclusively with bradycardia pacing or tachycardia pacing, rather than the mixture that occurs in Intensive and Coronary Care Units (lCU and CCU).
We undertook a prospective survey of all patients requiring temporary transvenous pacing in the ICU and CCU of Royal Perth Hospital to review our indications for pacing and the incidence of complications.
METHODS
During a six-month period (January I-June 30, 1980 inclusive) a prospective survey was carried out on all temporary transvenous pacing lead insertions. One hundred and three pacemaker electrodes were inserted in 98 patients. Follow-up was continued until removal of the pacemaker or death. In 1982 a further prospective study was undertaken of 50 consecutive transvenous pacemaker insertions in fifty patients. The purpose of the second survey was to see if our complication rate had altered during the intervening period. Included on the information form were the name, age, sex, reason for insertion, diagnosis, insertion time, route of insertion, complications at insertion (including remanipulation and/or replacement of the pacing lead), complications occurring after the electrode was in place (including pacing and sensing failure, possible cardiac perforation etc.) and complications occurring after removal (e.g. sepsis). Insertion time was the time between preparatory hand washing and satisfactory pacing.
Lead insertion: All lead insertions were performed in the Intensive Care or Coronary Unit by a clinical staff member of the unit or by a registrar of that unit. All beds were radiolucent and an image intensifier was immediately available on the floor. All lead insertions were accomplished under fluoroscopic control without moving the patient from the bed. Each was inserted percutaneously using a modified Seldinger technique. Different pacing leads were used depending on the arrhythmia and clinical setting: e.g. 5-French bipolar pacing electrodes were used for temporary ventricular demand pacing (VVI) in patients with complete heart block whereas quadrapolar electrodes were used extensively to diagnose and treat wide complex tachycardias (i.e. suspected ventricular tachycardia). Temporary atrial l-leads became available in 1982 and were occasionally used for atrial pacing and dual chamber pacing (with a ventricular lead). Pacing leads were commonly recycled in 1980, some as many as five times. This was unusual in 1982 except for quadrapolar electrodes.
After insertion: After lead placement the patients were continuously monitored until removal of the pacing lead or discharge from the ICU or CCU. Patients were only discharged to general wards if they were no longer considered to be pacemaker-dependent (i.e. had an adequate cardiac rhythm when the pacemaker was switched off). Pacing threshold and sensitivity were tested on insertion and usually daily thereafter. Prophylactic antibiotics were not given and the only anticoagulant used was low-dose heparin (5000 units subcutaneously 8 hourly).
Complications: Complications were divided into:
(1) Minor, e.g. arterial puncture or haematoma requiring no treatment. (2) Major. (i) Potentially harmful, e.g. right ventricular perforation without tamponade. (ii) Resulting in some serious actual harm to the patient, e.g. pneumothorax, pacing failure wi th ventricular asystole, pacing triggered ventricular tachycardia. Pacemaker malfunction requiring only changes in the pulse generator setting were not considered as complications. Ventricular premature beats and short self-terminating runs of ventricular tachycardia requmng no treatment were not considered significant. Failure to pace and/or sense, diaphragmatic pacing and/or a pericardial friction rub singly or in combination may indicate cardiac perforation. In this study each would be considered as a separate complication.
The data collected were analysed for the whole group and for the following subgroups:
(i) Bradycardia.
(ii) Wide complex tachycardia (i.e. suspected ventricular tachycardia). (iii) Narrow complex tachycardia (i.e. supraventricular tachyarrhythmias). Complication rates for 1980 and 1982 were compared.
The age of the patients ranged from 18 to 90 years with a mean age of 65.4 (standard deviation 11.6).
Insertion was undertaken on 105 occasions for bradyarrhythmias (Group 1), on 17 occasions for wide complex tachycardia (Group 2) and on 31 occasions for narrow complex tachycardia (Group 3).
Routes of insertion: The infraclavicular subclavian vein approach was the most commonly used, accounting for 111 (73070) insertions ( Table 1) 
Remanipu/ation at insertion:
This refers to changing the pacing lead at the time of insertion, usually due to unstable electrode position or intermittent failure to pace or sense. This was necessary in 11 (16%) of 68 insertions for Group I patients (bradycardia pacing) in 1980, but for none of 37 insertions in 1982. No patients in Group Il or Group III required early remanipulation.
Remanipu/ation after insertion: This was defined as replacing or retracting the pacing lead after initial placement. It was considered necessary on 8 (6%) occasions. Three of these occurred in 1980 and 5 in 1982. All were associated with complications.
Insertion time:
Median insertion time was 20 minutes (range from 5 to 135 minutes). The mean insertion time in the 1980 patients was 24.5 minutes and in the 1982 patients 35.5 minutes.
Time in situ: The pacing leads remained in situ for a median time of 52 hours (range 1 to 312 hours). The mean time in situ was 64.3 hours for patients in 1980 and 85.2 hours for those in 1982.
Diagnosis: A list of diagnoses is given in Table 2 . Acute myocardial infarction was the most common diagnosis in Groups I and n.
Indications for pacing electrode insertion:
Temporary pacing for bradyarrhythmias (actual or potential) was the reason for 61 % of all insertions (Table 3 ). Fifty-one per cent of these were in patients with acute myocardial infarction and 21 % had idiopathic complete heart block or failed permanent pacemaker. a) Bradyarrhythmias (Group I). Sixty-five (61 %) of the 105 lead insertions occurred in 100 patients with complete heart block or ventricular asystole. In 81 (77%) the bradycardia was associated with cardiac arrest, syncope, hypotension, severe heart failure or malignant ventricular tachyarrhythmias. Prophylactic pacing was undertaken in 17 (16%) instances. Severe bradyarrhythmias were documented in two instances. b) Tachyarrhythmias (Groups Il and Ill). (ii) Arrhythmia reversion (Table 4) . Reversion was successful in 13 (76%) of 17 patients with a wide complex tachycardia (Group 11). Failure occurred in 4 patients (24%). Inability to revert to sinus rhythm or only intermittent reversion to sinus rhythm with no significant effect on the patient's clinical condition was considered as failure. One patient with a wide complex tachycardia of 160/minute had a sinus tachycardia with bundle branch block. Reversion was successful in 28 (90%) of 31 patients with a narrow complex tachycardia. One patient in sinus tachycardia and one who converted to normal sinus rhythm while the pacing lead was being inserted were entered in the failure group. The commonest cause of a narrow complex tachycardia in this group was atrial flutter (Table 3 .) This occurred in 23 patients (74%), 21 of whom were converted to sinus rhythm with rapid atrial pacing. Paroxysmal supraventricular tachycardia accounted for 7 (23%) of narrow complex tachycardias. Pacing mode (Table 5) : Ninety-nine (94%) of 105 leads inserted in Group I were paced in the VVI (ventricular demand) mode. Patients with tachyarrhythmias were treated with 'burst' spacing of the ventricle (Group 11) or atrium (Group Ill).
Complications (table 6) Major
There were 11 (7%) major complications in 153 pacing episodes. No deaths were caused by pacing or failure to pace.
Nine (9%) of the 105 Group I pacemaker insertions were associated with major complications. Six (9%; total 68 insertions) occurred in 1980. In 1982 there were 3 (8%) Ventricular fibrillation occurred in one patient. The onset was 10 minutes after insertion and it is not certain whether this was pacemaker induced. There were two episodes of failure to pace resulting in ventricular asystole. One was due to failure to sense and the other to over sensing . Ventricular tachycardia was induced by pacing in four patients. These were almost certainly associated with sensing problems, but have been classified under the arrhythmia that they caused. Minor complications occurred in 14 (13070) of 105 pacing episodes.
Right ventricular perforation probably occurred in two patients. Cardiac perforation may occur without cardiac tamponade, radiological or echocardiographic signs. For this reason the incidence of right ventricular perforation may have been underestimated. Cardiac tamponade due to this cause was not seen in this survey. In Group If patients, VT was not considered a complication unless it was unresponsive to 'burst' pacing at a faster rate, did not revert spontaneously and required a D.C. shock.
One patient had a wide complex tachycardia at a rate of 160/minute. An intracardiac ECG showed A-V dissociation confirming the diagnosis of VT. 'Burst' ventricular pacing resulted in a sustained ventricular tachycardia of a different configuration at over 300 beats/minute (i.e. entrainment had occurred). The patient became unconscious and a D.e. shock at 200j resulted in normal sinus rhythm.
There was one episode of septicaemia in a patient with a pacemaker in situ. Blood cultures grew Staphylococcus aureus. Treatment was successful.
Minor
Minor complications did occur in 10070 of lead insertions. No arterial puncture nor haematoma required surgical intervention. Five (5OJo) cases of minor pacing and/or sensing failure occurred in Group I, 3 in 1980 and 2 in 1982. Although this was potentially harmful, there was no measurable change in the patients' clinical status. Diaphragmatic pacing occurred on 3 occasions. In one instance this was associated with sensing failure.
Failure to insert the pacing lead by the initial route occurred in 16% of all attempts in 1980 and 10% in 1982. Remanipulation at the time of insertion (i.e. before the operator un scrubbed) was necessary in 16% of insertions in Group I patients in 1980, but in none in 1982. No remanipulations were necessary in any Group 11 or Group III patients.
DISCUSSION

Indications for temporary cardiac pacing
Bradycardia (Group I): It is generally accepted that cardiac pacing is indicated for patients with a persistent symptomatic bradycardia. Seventy-seven per cent of our lead insertions were in patients with significant haemodynamic deterioration. This is greater than the 56% reported by Austen et al. 13 The majority of patients having prophylactic pacing leads inserted had an acute myocardial infarction with 'high-risk' bundle branch block. The criterion for electrode insertion in this subgroup were those of Hindman et al. 14, 15 Although it is difficult to assess the risk/benefit ratio of prophylactic pacing, two patients (12%) had a significant documented bradycardia. As 'standby' ventricular pacing (VVI) was employed, the incidence of bradyarrhythmias has probably been underestimated.
Wide complex tachycardia (Group 11): Many patients who were admitted to ICU or CCU with a wide co'mplex tachycardia were haemodynamically unstable and required immediate DC cardioversion. These patients were excluded from this study.
In 76% of instances where pacing electrodes were inserted to treat a wide complex tachycardia, an intracardiac ECG recorded via the pacing electrodes assisted in the differentiation between ventricular tachycardia and supraventricular tachycardia with aberrant conduction.
Most patients with a wide complex tachycardia had been given at least one drug, usually lignocaine 2mg/kg as a bolus, prior to pacing. The exceptions were those in whom the diagnosis of ventricular tachycardia was uncertain and specific arrhythmia diagnosis was considered essential for ongoing treatment.
Narrow complex tachycardia (Group Ill): Rapid atrial pacing was undertaken in patients with a persistent narrow complex tachycardia, resistant to multiple drugs and/or associated with haemodynamic deterioration of insufficient severity to require immediate cardioversion. Atrial flutter was the predominant diagnosis in our study because drug reversion may be difficult and pacing reversion is almost always successful. Paroxysmal supraventricular tachycardia is a common supraventricular arrhythmia, but unlike atrial flutter will usually respond to drug therapy.
There were three failures (10%). In one case rapid atrial pacing failed to convert atrial flutter to sinus rhythm. There were two patients in whom rapid atrial pacing was not attempted. They were considered as failures because an 'unnecessary' procedure had been performed. One patient was diagnosed as in sinus tachycardia. This patient benefited from the diagnosis in so far as further procedures such as cardioversion were not indicated. The other patient converted to normal sinus rhythm as the pacing lead was being inserted. The pacing lead may well have induced atrial ectopics (due to mechanical stimulation of the atrium) with consequent reversion. No therapeutic pacing was undertaken in the latter two cases. Thus rapid atrial pacing failed to convert a supraventricular tachyarrhythmia to sinus rhythm in only one case.
Insertion time: No other studies appear to have measured the time taken to insert a pacing lead. Time is critically important in situations where a bradycardia or tachycardia has resulted in severe haemodynamic deterioration. Tachyarrhythmias can be treated with DC cardioversion, but bradyarrhythmias can only be managed with drugs, external cardiac massage or pacing.
A senior member of the ICU staff was always available. Fluoroscopy could be utilised without moving either the patient or bed. In all urgent cases (i.e. symptomatic bradycardia, ventricular tachycardia, etc.) hand washing was immediately commenced after the decision to Problems and minor complications: The most likely explanation for the difference in the rate of necessity of remanipulating the lead is that in 19S0 the pacing leads were commonly recycled. This resulted in an increasingly 'floppy' lead which was more likely to dislodge. Unlike Austen 13 we do not consider minor pacing malfunctions to be relevant to clinical management. These malfunctions were usually transient, requiring minor adjustments to the pacing generator or connections, or no intervention. There were no serious complications due to pacemaker generator or lead failure in this study.
Inadvertent right ventricular pacing in attempted universal dual-chamber (DDD) pacing occurred on two occasions, when a converted permanent DDD pacemaker was used. Permanent DDD pacemakers are usually unipolar and the anode in each lead shares a common ground. This may result in crosssensing (i.e. the atrial part of the pacemaker senses ventricular activity as atrial activity) causing triggered ventricular pacing after the set atrioventricular (A V) delay. This can easily be rectified by convering to the A-V sequential (DV I) mode. Recently other methods for employing temporary external DD pacing have been described. 16, 17 Major complications: Ventricular fibrillation (VF) occurred in one patient with bradycardia, 10 minutes after insertion. It is not certain that this arrhythmia was pacemaker-induced. The patient had sustained an inferior myocardial infarction. Sensing difficulties are often encountered in patients with inferior infarcts and this may lead to VF I8 and VT. 19 ,20 However such sensing problems were not documented in this case. The VF did not recur after conversion to sinus rhythm with a 200j DC shock and antiarrhythmic drugs. Pacemaker-triggered ventricular tachycardia was documented in one case and was suspected of being the cause of VT in three other patients.
Failure to pace resulted in asystole on one occasion. The patient was kept alive by praecordial thumps, external cardiac massage Anuesthesia and Infensive Care, Vol. 13, No. /, February, 1985 and drugs until a new pacing lead was successfully inserted. Over sensing resulted in failure to pace and ventricular asystole in another patient. Changing the pacing mode from ventricular demand (VVI) to fixed rate ventricular (VOO) pacing rapidly reinstituted cardiac pacing, although the patient did lose consciousness transiently.
In one patient who developed septicaemia, immediate removal of the pacing lead and treatment with intravenous Cloxacillin were successful. Narrow complex tachycardia is a relatively benign condition and so the incidence of complications with a zero mortality rate is acceptable.
Overall, a complication occurred in 27 (ISOJo) of 153 lead insertions, 11 (7%) of these being serious. Near-fatal complications due to failure of the pacing system to pace the heart in the presence of a severe bradycardia was seen in two patients. Absence of a pacing system would obviously not have prevented these bradycardias. The remaining complications were those of lead insertion or related to the presence of a pacing lead in the right ventricle (i.e. occurred because pacing had been undertaken). No patient died as a result of temporary transvenous cardiac pacing. No patient's death was considered to have been contributed to by pacing.
We conclude that temporary transvenous pacing is a safe and effective treatment modality for bradyarrhythmias and tachyarrhythmias.
